Skip to main content
. 2014 Aug 12;9:26. doi: 10.1186/1750-9378-9-26

Table 2.

Univariate and multivariate logistic regression results modeling CIN3 presence/absence or HPV co-infections

Outcome Covariate(s) Odds ratio 95% CI p value
Presence of CIN3
Multiple types single species
0.4145
0.177-0.970
0.042
Presence of CIN3
Multiple types different species
0.6753
0.252-1.808
0.435
Presence of CIN3
Multiple types single high-risk species
0.3696
0.159-0860
0.021
Presence of CIN3
HPV 16 or 18
0.8127
0.358-1.843
0.620
Presence of CIN3
Age
1.0204
0.951-1.095
0.576
Presence of CIN3
Sexual Partners*
0.9997
0.909-1.099
0.994
Presence of CIN3
Age at First Sex*
1.0722
0.861-1.336
0.534
Presence of CIN3
CD4 count at presentationϮ
1.0014
0.998-1.004
0.297
Presence of CIN3
Last available CD4 count
1.0003
0.998-1.002
0.746
Presence of CIN3
Multiple types from single species; high-risk HPVǂ
0.3783
0.159-0.899
0.028
Presence of CIN3
Multiple types from single species; HPV 16 or 18
0.4138
0.172-0.996
0.049
Presence of CIN3
Multiple types from different species; high-risk HPVǂ
0.6061
0.225-1.632
0.322
Presence of CIN3
Multiple types from different species; HPV 16 or 18
0.6980
0.256-1.900
0.482
Presence of CIN3
Multiple types from single high-risk species; high-risk HPVǂ
0.4158
0.177-0.975
0.044
Presence of CIN3
Multiple types from single high-risk species; HPV 16 or 18
0.3661
0.155-0.847
0.024
2+ HPV infections
CD4 count at presentation
0.9978
0.995-1.001
0.168
2+ HPV infections
Last available CD4 count
0.9980
0.995-1.001
0.130
Multiple types single species
CD4 count at presentation
1.0001
0.998-1.002
0.963
Multiple types single species
Last available CD4 count
0.9995
0.998-1.001
0.618
Multiple types single high-risk species
CD4 count at presentation
1.0006
0.998-1.003
0.623
Multiple types single high-risk species
Last available CD4 count
1.0008
0.999-1.003
0.413
Multiple types different species
CD4 count at presentation
0.9980
0.995-1.001
0.187
Multiple types different species Last available CD4 count 0.9981 0.996-1.000 0.106

Data available for 63 patients* and for 61 patientsϮ. 90 patients had high risk HPV typesǂ.